OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 03, 16:00
OncoSec Medical Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2023 | -0.0115M |
| October 31, 2022 | 0.00 |
| July 31, 2022 | 0.00 |
| April 30, 2022 | 0.00 |
| January 31, 2022 | -0.2449M |
| October 31, 2021 | 0.00 |
| July 31, 2021 | -0.0449M |
| April 30, 2021 | -0.5047M |
| January 31, 2021 | -0.25M |
| October 31, 2020 | 0.00 |
| July 31, 2020 | 0.00 |
| April 30, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 1.00M |
| April 30, 2019 | 3.240M |
| January 31, 2019 | 5.232M |
| October 31, 2018 | 13.73M |
| July 31, 2018 | -0.004M |
| April 30, 2018 | -23.28M |
| January 31, 2018 | -0.0082M |
| October 31, 2017 | 0.00 |
| July 31, 2017 | -0.012M |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2016 | -0.0096M |
| July 31, 2016 | -0.3943M |
| April 30, 2016 | -0.0955M |
| January 31, 2016 | -0.5798M |
| October 31, 2015 | -0.4811M |
| July 31, 2015 | -0.6695M |
| April 30, 2015 | -0.1982M |
| January 31, 2015 | -0.1301M |
| October 31, 2014 | -0.4334M |
| July 31, 2014 | -0.3584M |
| April 30, 2014 | -0.0989M |
| January 31, 2014 | -0.0438M |
| October 31, 2013 | -0.0115M |
| July 31, 2013 | -0.0978M |
| April 30, 2013 | -0.0136M |
| January 31, 2013 | -0.0032M |
| October 31, 2012 | 0.00 |
| July 31, 2012 | -0.0312M |
| April 30, 2012 | -0.0031M |
| January 31, 2012 | -0.0029M |
| October 31, 2011 | -0.0173M |
| July 31, 2011 | -0.0436M |
| April 30, 2011 | -0.2677M |
| January 31, 2011 | 0.00 |
| October 31, 2010 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
| Vericel Corp. | -2.82M |